We are delighted to announce the launch of the West Midlands Health Tech Innovation Accelerator (WMHTIA) and share our involvement in the project, which aims to help and support new healthcare technologies in their drive towards commercialisation.

The WMHTIA has received £14 million in funding from the West Midlands Combined Authorities’ Innovation Accelerator which is part of an Innovate UK funded programme.

Medilink Midlands is one of several key organisations across the region joining the University of Birmingham in a programme focused on addressing the challenges of bringing new medical and healthcare technologies into the UK market.

It aims to promote collaboration with universities, hospitals, industry and government-funded ‘catapults’ for manufacturing innovation, helping companies to navigate ‘pinch points’ in the commercialisation process.

The purpose of the project is to create a cluster of commercial activity, helping drive economic growth and enhance resilience. Importantly, it will also ensure that local patients will benefit first from new medical technologies targeted at reducing healthcare inequalities in the region.

West Midlands Health Tech Innovation Accelerator delivery organisations:

Locally-led Innovation Accelerators delivered in partnership with DSIT, Innovate UK and City Regions

Latest Opportunities

Exporting Starts Here programme for West Midlands companies

West Midlands Combined Authority (WMCA), funded by the UK Shared Prosperity Fund (UKSPF), has commissioned…

NIHR i4i Connect funding call

The NIHR Invention for Innovation (i4i) programme is accepting outline applications to their latest researcher-led Connect funding…

Study brief: The effects of a recovery gel on endurance cycling performance in the heat

The popularity of endurance sports like cycling and running has grown significantly over the past…

Latest News

Blog: Why cleanrooms are essential for medical-grade cannabis companies

By Medilink Midlands Member Airology Systems The demand for medical-grade cannabis has surged in recent…

Australia’s Cannim partners with PHTA to advance medicinal cannabis research

Leading medicinal cannabis company Cannim has announced its UK operations will be based at Birmingham’s…

New sleep trial shows dramatic benefits for participants

Cambridge Sleep Sciences (CSS), a leading UK innovator in sleep technology, has announced groundbreaking results…